Research · Sep 3, 2026
Lockheed Martin FY2025 revenue ~$73B (+3-5% YoY) with adj. EPS ~$28.00 — pure-play defense prime contractor with ~70% US DoD + ~25% international + ~5% civilian government revenue. F-35 program (largest single revenue contributor at ~25-30% / ~$20B) progressing through TR-3 software upgrade resolution: deliveries recovering from FY2023 trough (~98 deliveries) toward FY2025 target ~150. Missiles & Fire Control segment scaled production capacity ~2x prior on PAC-3 (Patriot interceptor) demand from Ukraine + Middle East + international. Backlog ~$165B record. FY2026 thesis: F-35 normalization continues + Missiles capacity scaling capturing elevated demand + Space classified programs delivering on development cycles + 22nd consecutive year of dividend growth; key risks: F-35 program execution issues persisting, US DoD budget compression, classified space program cost overruns.
Research · Jun 8, 2026
House blocks Trump on Iran. Israel-Lebanon ceasefire. LMT $512, RTX $172, NOC $526 — cohort sells off but defense budget trajectory intact.
Research · Jun 6, 2026
FT reports the NSA is using Anthropic's Mythos for cyber operations as the US doubles down on defense AI. What the catalyst means for PLTR, LMT, and HII.
Research · Apr 23, 2026
Brent crude topping $100/barrel on Strait of Hormuz concerns reveals a mispricing in energy stocks still trading on lower oil price assumptions. XOM and CVX offer 15-20% upside as earnings revisions catch up to triple-digit oil reality, with LMT benefiting from elevated Middle East defense spending. The thesis breaks if oil retreats below $85 by Q3 2025.
Research · Apr 13, 2026
Artemis II's safe return on April 11, 2026, de-risks NASA's lunar program, favoring contractors like LMT and NOC with direct hardware roles. We rank six stocks by exposure, ranking LMT highest for its Orion primacy and steady growth. Risks include delays and competition from private launchers.
Research · Apr 13, 2026
Hezbollah's intensified attacks on Israel, killing 14 in Lebanon ahead of U.S.-Iran talks, signal rising demand for LMT and RTX missile systems amid $462B backlogs, while XOM benefits from Middle East supply fears boosting oil. Defense stocks show strong YTD gains (LMT +30%, RTX +10%), with XOM up 28% on resilient production guidance. Bullish: Escalation drives orders and pricing power.
Research · Apr 13, 2026
Policy rifts between Trump and Netanyahu over Iran elevate US defense spending and oil risks, benefiting LMT, NOC, RTX, GD, XOM, and CVX. Defense firms show record backlogs and production ramps; energy majors leverage low-cost assets amid supply threats. NOC and LMT top the conviction list.
Research · Apr 13, 2026
Israeli strikes in Lebanon on April 9 threaten the Iran-US ceasefire, spiking oil to $110/bbl and lifting energy sentiment for XLE. Defense leaders LMT and NOC, with $75B/$42B revenues and record backlogs, are primed for missile demand amid Hezbollah risks—bullish on dips with 5-11% sales growth guided.
Research · Apr 13, 2026
The announced US-Iran truce steadied European gas but sparked an oil pullback, pressuring XOM while LMT held gains on defense tailwinds. SPY faces volatility from diplomatic uncertainty. Investors should favor LMT's backlog resilience over XOM's exposure, with SPY as a tactical hedge.
Research · Apr 13, 2026
Trump's April 13 oil blockade announcement idled Iranian tankers off India, boosting LMT's defense prospects via missile demand while pressuring XOM's Middle East ops. LMT's $141B cap and 29.8% YTD gains position it for outperformance; XOM's integrated model weathers supply risks at $110 oil. Bullish on LMT, hold XOM amid escalating tensions.
Research · Apr 13, 2026
Trump's April 13 Iran port blockade boosts LMT's missile demand via $194B backlog, while XOM navigates supply risks with strong Permian/Guyana output. LMT eyes 2026 EPS jump to $30; XOM's FCF resilience caps downside. Bullish defense, neutral energy play.
Research · Apr 13, 2026
US-Iran talks stalemated on April 12, driving oil over $100 and pressuring futures, boosting XOM's valuation and LMT's backlog while SPY faces risk-off flows. XOM's $23.6B FCF and low debt position it for margin gains; LMT's 29.8% YTD run holds firm. Overweight energy/defense amid policy fog.
Research · Apr 13, 2026
Trump's April 12 Strait of Hormuz blockade announcement threatens 20% of global oil flows, hitting XOM's Middle East assets but poised to drive crude toward $150. LMT benefits from defense ramp-up amid escalation, with both posting 28-30% YTD gains on cheap valuations. Bullish outlook as supply shocks outweigh near-term volatility.
Research · Apr 13, 2026
Trump's April 12 Hormuz blockade threat after Iran talks fail risks 20% of global oil flows, supercharging LMT's $194B defense backlog while pressuring XOM's supply chains. LMT eyes 15% upside on missile ramps; XOM/USO neutral amid volatility. Bullish LMT, watch Navy orders and OPEC.
Research · Apr 13, 2026
Trump's warning over China's alleged anti-air missiles to Iran heightens Middle East risks, positioning Lockheed Martin and Northrop Grumman for backlog growth amid record demand, while XLE grapples with oil volatility. LMT and NOC boast strong financials—$75B/$44B sales guidance, robust FCF—trading at reasonable multiples with 38-50% 1Y gains. Investors should favor defense over energy as U.S. aid ramps.
Research · Apr 13, 2026
JD Vance's announcement of collapsed 21-hour US-Iran talks in Pakistan on April 12 threatens the ceasefire, revitalizing oil supply risks and defense demand. XOM and CVX stand strong with 26-28% YTD gains and robust margins, while LMT and NOC's massive backlogs position them for growth. Bullish outlook as escalation premiums lift valuations.
Research · Apr 13, 2026
JD Vance's April 12 announcement of failed 21-hour US-Iran talks in Pakistan threatens the ceasefire and Iran's uranium stockpile security, priming LMT and NOC for missile defense windfalls atop record backlogs and upbeat guidance. Despite recent dips, strong financials and geopolitical tailwinds warrant bullish positioning ahead of potential escalations.
Research · Apr 13, 2026
Reuters' April 11 report on US-Iran talks in Pakistan highlights key issues like Hormuz access, as XOM reveals $1B+ Q1 hits from Middle East disruptions affecting 20% of production. Energy stocks like XOM and XLE stand to gain from potential supply relief, while LMT's defense backlog faces de-escalation risks. Bullish shift to energy recommended ahead of Q2 finalization.
Research · Apr 13, 2026
Boeing's SLS faces Trump NASA scrutiny, per April 11 Bloomberg report, boosting Lockheed, Northrop, Rocket Lab, BWXT, and Intuitive Machines for lunar bases and nuclear propulsion. LMT and NOC top ranked for stability; BA lags. Article analyzes financials and exposure.
Research · Apr 13, 2026
April 11's global oil panic buying amid Middle East risks highlights tailwinds for XOM and LMT, with Exxon's record production and Lockheed's $194B backlog set for boosts. Recent returns show resilience (XOM +7.6% 1M, LMT +35.9% 3M), supporting a bullish overweight amid potential $90-100/bbl crude.
